First Australian Guideline for Pediatric Hypertension Identification and Management
This inaugural Australian pediatric hypertension guideline, adapted from the AAP 2017 framework, gives pharmacists a unified national reference for BP thresholds, screening timing, and antihypertensive selection in patients under 18 years of age.
Australian Guideline for Hypertension in Children and AdolescentsBPOzKids NetworkHypertension Australiapaediatric hypertensionchronic kidney diseaseACE inhibitorsARBscalcium channel blockersthiazide diureticsPediatric Pharmacy
Background Information
New guidelines tackle rising pediatric hypertension issues.
Hypertension in children and adolescents is a growing concern, requiring specific guidelines for effective management. The guideline provides updated criteria for diagnosis and recommendations for management strategies. These guidelines help standardize the approach to diagnosing and managing pediatric hypertension, an area with previously limited resources. New guidelines aim to improve hypertension management in young populations through standardized practices.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Authors:Larkins NG, Medley T, Black A, Bolton KA, Chaturvedi S, Clark M, Gabb GM, Glenning JP, Grimes C, Huang RC, Hyland A, Jeffries-Stokes C, Kalman L, Kaul S, Kim S, McTaggart S, Kowalski R, Li SX, McNab S, Metz D, Mihailidou AS, Monin J, Nelson M, Pathak M, Roebuck D, Schlaich MP, Sleaby R, Quinlan C, Mynard JP
Citation:Larkins NG, Medley T, Black A, et al. Australian Guideline for the Identification and Management of Hypertension in Children and Adolescents. Journal of paediatrics and child health. 2026. doi:10.1111/jpc.70491
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.